Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 2/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31559147 | 1.00 | EPHX1 (0.42) | EPHX1CA1CA2CA4ACHE | |
| SCHEMBL31746167 | 1.00 | EPHX1 (0.42) | EPHX1CA1CA2CA4ACHE | |
| SCHEMBL1269311 | 0.96 | EPHX1 (0.40) | EPHX1CA1CA2CA4ACHE | |
| SCHEMBL28354173 | 0.95 | CA1 (0.40) | EPHX1CA1CA2CA4ACHE | |
| Methylcyclopentane SCHEMBL862 | 0.95 | — | — | |
| Cycloheptane SCHEMBL23885013 | 0.91 | ACHE (0.43) | EPHX1CA1CA2CA4ACHE | |
| Methylcyclopentane SCHEMBL8234171 | 0.91 | — | — | |
| SCHEMBL5189 | 0.91 | — | — | |
| Cyclohexane SCHEMBL3670822 | 0.91 | ACHE (0.43) | EPHX1CA1CA2CA4ACHE | |
| SCHEMBL15121491 | 0.91 | ACHE (0.43) | EPHX1CA1CA2CA4ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240344094-A1 | METHODS AND COMPOSITIONS USEFUL FOR THE PRODUCTION OF OLEFINIC ESTER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-10-17 | — | — | US | claimed |
| US-20240158816-A1 | METHODS AND COMPOSITIONS FOR THE PRODUCTION AND DEHYDRATION OF ISOPRENOL INTO ISOPRENE | U.S. DEPARTMENT OF ENERGY | 2024-05-16 | — | — | US | claimed |
| WO-2023077017-A1 | METHODS AND COMPOSITIONS USEFUL FOR THE PRODUCTION OF OLEFINIC ESTER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-05-04 | — | — | WO | claimed |
| US-20260117135-A1 | SYSTEMS AND METHODS FOR PRODUCING A DIMETHYLCYCLOOCTANE-BASED AVIATION FUEL FROM ISOPRENE | CleanJoule, Inc. (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260092023-A1 | PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS | VISOLIS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260092228-A1 | COMPOSITIONS FOR FUEL BLENDING MADE BY A SUSTAINABLE PROCESS, AND SUSTAINABLE FUEL COMPOSITIONS THEREFROM | VISOLIS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260092130-A1 | PROCESS FOR SYNTHESIZING POLYMER COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND | VISOLIS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260062631-A1 | CYCLOOCTANE CONTAINING FUEL COMPOSITIONS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2026-03-05 | — | — | US | disclosed |
| US-20260028433-A1 | PROCESS FOR SYNTHESIZING TACKIFYING COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND | VISOLIS INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20260028545-A1 | SUSTAINABLE AVIATION FUEL COMPOSITIONS | VISOLIS INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20260028539-A1 | COMPOSITIONS FOR PRODUCTION OF OLEFINS, TERPENES, AROMATICS AND CYCLOALIPHATICS AND METHODS THEREFOR, AND PRODUCTS THEREFROM | VISOLIS INC (US) | 2026-01-29 | — | — | US | disclosed |
| EP-0823423-B1 | 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2004-06-16 | — | — | EP | disclosed |
| US-6140338-A | FOR TREATING ACUTE INFLAMMATORY DISEASES, CHRONIC INFLAMMATORY DISEASES, ACQUIRED IMMUNE DEFICIENCY SYNDROME, CANCER, ISCHEMIC REFLOW DISORDER AND/OR ARTERIOSCLEROSIS | BANYU PHARMACEUTICAL, CO., LTD. (JP) | 2000-10-31 | — | — | US | disclosed |
| US-6040449-A | USEFUL FOR FORMING FLUORINE CONTAINING 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES, USEFUL AS ANTAGONIST FOR MUSCARINIC M3 RECEPTORS AND LESS SIDE EFFECT | BANYU PHARMACEUTICAL CO LTD (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5948792-A | POTENT AND SELECTIVE ANTAGONISTS FOR MUSCARINIC M.SUB.3 RECEPTORS WITH LITTLE SIDE EFFECTS. | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0930298-A1 | FLUORINATED 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-07-21 | — | — | EP | disclosed |
| EP-0916668-A1 | CHEMOKINE RECEPTOR ANTAGONISTS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-05-19 | — | — | EP | disclosed |
| US-5750540-A | SIDE EFFECT REDUCTION | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-05-12 | — | — | US | disclosed |
| EP-0823423-A1 | 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-02-11 | — | — | EP | disclosed |
| US-4739120-A | RHODIUM CATALYST, BASIC SOLUTION OR IMMISCIBLE ORGANIC SOLVENT AND WATER | THE DOW CHEMICAL COMPANY (US) | 1988-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240158816-A1 | METHODS AND COMPOSITIONS FOR THE PRODUCTION AND DEHYDRATION OF ISOPRENOL INTO ISOPRENE | MSMO1, DHCR7, ICMT | EPHX1 355/4885CA1 1270/4885CA2 2116/4885 |
| US-20260028433-A1 | PROCESS FOR SYNTHESIZING TACKIFYING COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND | FZD7, WNT1, SFRP1 | EPHX1 3463/4885CA1 2951/4885CA2 2943/4885 |
| US-20260117135-A1 | SYSTEMS AND METHODS FOR PRODUCING A DIMETHYLCYCLOOCTANE-BASED AVIATION FUEL FROM ISOPRENE | ERG28, DIMT1, MSMO1 | EPHX1 2741/4885CA1 1725/4885CA2 1069/4885 |
| US-20260092228-A1 | COMPOSITIONS FOR FUEL BLENDING MADE BY A SUSTAINABLE PROCESS, AND SUSTAINABLE FUEL COMPOSITIONS THEREFROM | CYP4F12, CYP4F11, CYP4F8 | EPHX1 960/4885CA1 2799/4885CA2 3036/4885 |
| US-20260092023-A1 | PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS | CYP4A11, HMGCR, FADS1 | EPHX1 841/4885CA1 2171/4885CA2 2831/4885 |
| US-20260062631-A1 | CYCLOOCTANE CONTAINING FUEL COMPOSITIONS | CPT1A, CPT2, CNR2 | EPHX1 1756/4885CA1 2071/4885CA2 1134/4885 |
| US-20260092130-A1 | PROCESS FOR SYNTHESIZING POLYMER COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND | SAMM50, MAX, HSF1 | EPHX1 2088/4885CA1 3770/4885CA2 3259/4885 |
| US-20260028539-A1 | COMPOSITIONS FOR PRODUCTION OF OLEFINS, TERPENES, AROMATICS AND CYCLOALIPHATICS AND METHODS THEREFOR, AND PRODUCTS THEREFROM | CYP4F11, FDFT1, CYP4A11 | EPHX1 1037/4885CA1 2560/4885CA2 2989/4885 |
| US-20260028545-A1 | SUSTAINABLE AVIATION FUEL COMPOSITIONS | CYP4F12, CYP4F11, CYP4F8 | EPHX1 1718/4885CA1 1074/4885CA2 838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.